Chris Gibson

Chris Gibson's voice stands out for his ability to bridge the gap between tech and biotech, often highlighting the misconceptions and missed opportunities in the intersection of these fields. He pushes for a more nuanced understanding of AI's role in drug discovery, as seen in his post 'The Wrong Benchmark for AI Drug Discovery'. His distinctive angle is further evident in his willingness to discuss the challenges and criticisms facing the TechBio industry, such as the 'dip' in investment and interest.